Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers

Business Wire11-19 22:00

Two New Programs Aim to Improve Awareness and Support for Patients with Severe COPD/Emphysema REDWOOD CITY, Calif., November 19, 2024--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx"), ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2484947848?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5exdiGMCgA8pU.EzOJApPQ--~B/aD0yNDA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/fd887e3e3118462337f7ec9d5c31ee04","is_english":true,"pubTime":"2024-11-19 22:00","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2484947848","market":"us","top_or_hot":-1,"title":"Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers","media":"Business Wire","content":"<div>\n<p>Two New Programs Aim to Improve Awareness and Support for Patients with Severe COPD/Emphysema\nREDWOOD CITY, Calif., November 19, 2024--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (\"Pulmonx\"), ...</p>\n\n<a href=\"https://finance.yahoo.com/news/pulmonx-partners-american-lung-association-140000839.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-19 22:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/pulmonx-partners-american-lung-association-140000839.html><strong>Business Wire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Two New Programs Aim to Improve Awareness and Support for Patients with Severe COPD/Emphysema\nREDWOOD CITY, Calif., November 19, 2024--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (\"Pulmonx\"), ...</p>\n\n<a href=\"https://finance.yahoo.com/news/pulmonx-partners-american-lung-association-140000839.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0788108826.HKD","symbol_name":"BGF WORLD GOLD \"A2\" (HKDHGD) ACC","start_time":0,"source_url":"https://finance.yahoo.com/news/pulmonx-partners-american-lung-association-140000839.html","article_id":"2484947848","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5exdiGMCgA8pU.EzOJApPQ--~B/aD0yNDA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/fd887e3e3118462337f7ec9d5c31ee04"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2484947848","pubTimestamp":1732024800,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Two New Programs Aim to Improve Awareness and Support for Patients with Severe COPD/Emphysema. REDWOOD CITY, Calif., November 19, 2024----Pulmonx Corporation  , a global leader in minimally invasive treatments for severe lung disease, and the American Lung Association are continuing their ongoing collaboration with two new programs aimed at supporting patients with severe COPD and emphysema.Building on their successful partnership, the two organizations will launch new resources to educate patients and healthcare providers on innovative treatment options like the Zephyr Endobronchial Valve, a minimally invasive therapy for advanced COPD/emphysema. According to the World Health Organization , COPD remains the third leading cause of death worldwide, with millions of patients struggling to breathe and maintain quality of life despite medical management.As part of this collaboration, Pulmonx and the Lung Association will introduce two new programs to empower patients and clinicians:. The A","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0788108826.HKD":"BGF WORLD GOLD \"A2\" (HKDHGD) ACC","BK4082":"医疗保健设备","BK4588":"碎股","LU0724618789.USD":"BGF WORLD GOLD \"A4\" (USD) INC","LU1223083913.SGD":"Schroder ISF Global Gold A Acc SGD-H","BK4198":"医疗保健用品","LU0345781412.USD":"NINETY ONE GSF GLOBAL NATURAL RESOURCES \"A\" (USD) INC","LU0055631609.USD":"贝莱德世界黄金基金A2","LU1223082196.USD":"施罗德环球黄金A Acc","LUNG":"Pulmonx Corp","LU0075056555.USD":"贝莱德世界矿业基金A2","GOLD":"巴里克黄金","LU0345780281.USD":"NINETY ONE GSF GLOBAL GOLD \"A\"  ACC","BK4117":"多元化保险","AFG":"美国金融集团有限公司","LU0368265764.SGD":"Blackrock World Gold Fund A2 SGD-H","LU0496367417.USD":"富兰克林黄金和贵金属A（acc）","LU0498741890.SGD":"FTIF - Franklin Gold and Precious Metals A (acc) SGD","LU0330918003.SGD":"Blackrock World Mining A2 SGD-H","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC","BK4017":"黄金","BK4107":"财产与意外伤害保险","BK4532":"文艺复兴科技持仓","LU0345780950.USD":"NINETY ONE GSF GLOBAL NATURAL RESOURCES \"A\" (USD) ACC","BK4570":"地缘局势概念股","SG9999001143.SGD":"United Gold and General A Acc SGD","LU0498741114.HKD":"FRANKLIN GOLD & PRECIOUS METALS \"A\" (HKD) ACC","LU0345780521.USD":"NINETY ONE GSF GLOBAL GOLD \"A\" (USD) INC","BK4585":"ETF&股票定投概念","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","LU0630314457.HKD":"NINETY ONE GSF GLOBAL NATURAL RESOURCES \"A\" (HKD) ACC","LU1023059493.AUD":"Blackrock World Mining A2 AUD-H"},"translate_title":"Pulmonx与美国肺脏协会合作，为COPD患者和提供者推出新的教育计划","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AFG":1,"LUNG":1,"GOLD":1},"content_text":"Two New Programs Aim to Improve Awareness and Support for Patients with Severe COPD/Emphysema\nREDWOOD CITY, Calif., November 19, 2024--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (\"Pulmonx\"), a global leader in minimally invasive treatments for severe lung disease, and the American Lung Association are continuing their ongoing collaboration with two new programs aimed at supporting patients with severe COPD and emphysema.\nBuilding on their successful partnership, the two organizations will launch new resources to educate patients and healthcare providers on innovative treatment options like the Zephyr® Endobronchial Valve, a minimally invasive therapy for advanced COPD/emphysema. According to the World Health Organization (WHO), COPD remains the third leading cause of death worldwide, with millions of patients struggling to breathe and maintain quality of life despite medical management.\nAs part of this collaboration, Pulmonx and the Lung Association will introduce two new programs to empower patients and clinicians:\n\nIn November 2024, the Lung Association’s EACH BREATH blog will feature stories from two patients with diverse backgrounds who received endobronchial valve (EBV) treatment, sharing their journeys, decisions, and insights on life before and after the procedure.\nIn January, a leading pulmonologist will host an \"Ask the Expert\" session on the Lung Association's supported \"Living with COPD\" and \"Living with Lung Disease\" online communities. The Q&A will be archived on the platform as a lasting resource for patients exploring severe COPD/emphysema treatment options.\n\n\"We are excited to continue our partnership with the American Lung Association and together build awareness about the life-changing benefits of the Zephyr Valve therapy,\" said Steve Williamson, CEO of Pulmonx. \"COPD is a debilitating disease. We want patients and their physicians to know that there are treatment options available to help them breathe easier and live more active lives.\"\n\"A COPD diagnosis can be devastating for an individual and their family to hear, but thankfully there are treatment options available to help improve the lives of people living with this disease,\" said Deb Brown, Chief Mission Officer of the American Lung Association. \"An important part of living with COPD is being educated on the latest treatments and guidelines. The American Lung Association is proud to partner with Pulmonx to further our commitment to support those affected by COPD and offer a variety of resources and information about the disease.\"\nThe Lung Association collaboration will also build upon the existing educational content available to both patients and healthcare professionals, ensuring that those affected by COPD can make informed decisions about their treatment options.\nAbout the American Lung Association\nThe American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to champion clean air for all; to improve the quality of life for those with lung disease and their families; and to create a tobacco-free future. For more information about the American Lung Association, which has a 4-star rating from Charity Navigator and is a Platinum-Level GuideStar Member, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org. To support the work of the American Lung Association, find a local event at Lung.org/events.\nAbout Zephyr Valves\nThe Zephyr Endobronchial Valve is a minimally invasive treatment option for severe COPD/emphysema. Zephyr Valves are placed via bronchoscopy to block off a diseased portion of the lung to prevent air from getting trapped and reduce hyperinflation, which allows the healthier lung tissue to expand and take in more air. This results in patients being able to breathe easier, be less short of breath, and have an improvement in their quality of life.1 National and global treatment guidelines for COPD include Endobronchial Valves like Zephyr Valves as a recommended treatment option for patients with severe COPD/emphysema, with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) giving valves an ‘Evidence A’ rating. More than 40,000 patients have been treated with Zephyr Valves worldwide.\nAbout Pulmonx Corporation\nPulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD). Pulmonx’s Zephyr® Endobronchial Valve, Chartis® Pulmonary Assessment System, LungTraX™ Platform and StratX® Lung Analysis Report are designed to assess and treat patients with severe emphysema/COPD who despite medical management are still profoundly symptomatic. Pulmonx received FDA pre-market approval to commercialize the Zephyr Valve following its designation as a \"breakthrough device.\" The Zephyr Valve is commercially available in more than 25 countries, is included in global treatment guidelines and is widely considered a standard of care treatment option for improving breathing, activity and quality of life in patients with severe emphysema. For more information on the Zephyr Valves and the company, please visit www.Pulmonx.com.\nReferences1Criner G et al. Am J Respir Crit Care Med. 2018; 198 (9): 1151–1164.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20241119814005/en/\nContacts\nMedia Contact: Marcee Maroneymmaroney@pulmonx.com","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2484947848"}